Effects of everolimus on cytokines, oxidative stress, and renal histology in ischemia-reperfusion injury of the kidney

Renal Failure

Volumn 31, Issue 8, 2009, Pages 698-703

  Suyani, Elif ^a   Derici, Ulver Boztepe ^b   Sahin, Tolga ^b   Ofluoglu, Ebru ^c   Pasaoglu, Hatice ^b   Erdem, Ozlem ^b   Barit, Gonca ^b   Reis, Kadriye Altok ^b   Erten, Yasemin ^b   Arinsoy, Turgay ^b   Sindel, Sukru ^b  

^a GAZI UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Everolimus; Ischemia; Ischemia reperfusion; Kidney failure; Renal injury

Indexed keywords

CREATININE; EVEROLIMUS; INTERLEUKIN 6; MALONALDEHYDE; MYELOPEROXIDASE; NITROGEN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY ISCHEMIA REPERFUSION INJURY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CYTOKINES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY; SIROLIMUS;

EID: 70350700747     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903134555     Document Type: Article

References (30)

1. Bonventre JV, Zuk A. Ischemic acute renal failure: An inflammatory disease? Kidney Int. 2004;66:480-485.
2. Lameire N, Biesen WV, Vanholder R. Acute renal failure. Lancet. 2005;365:417-430.
3. Sheridan AM, Bonventre JV. Pathophysiology of ischemic acute renal failure. Contrib Nephrol. 2001;132:7-21.
4. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: Role in the extension phase of acute renal failure. Kidney Int. 2004;66:496-499.
5. Augustine JJ, Hricik DE. Experience with everolimus. Transplant Proc. 2004;36(Suppl. 2):500-503.
6. Tan HP, Basu A, Shapiro R. Everolimus: An update. Curr Opin Organ Transplant. 2003;8:323-326.
7. Schuurman HJ, Pally G, Weckbecker G, et al. SDZ RAD inhibits cold ischemia-induced vascular remodeling. Transplant Proc. 1999;31:1024-1025.
8. Lehle K, Birnbaum DE, Preuner JG. Predominant inhibition of interleukin-6 synthesis in patient-specific endothelial cells by mTOR inhibitors below a concentration range where cell proliferation is affected and mitotic arrest takes place. Transplant Proc. 2005;37:159-161.
9. Puglisi RN, Strande L, Santos M, et al. Beneficial effects of cyclosporine and rapamycin in small bowel ischemic injury. J Surg Res. 1996;65:115-118.
10. Reis F, Parada B, Teixeira de Lemos E, et al. Hypertension induced by immunosuppressive drugs: A comparative analysis between sirolimus and cyclosporine. Transplant Proc. 2009;41:868-873.
11. Crowe A, Bruelisauer A, Duerr L, et al. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab Dispos. 1999;27:627-632.
12. Kirchner GI, Meier-Wiedenbach I, Manns MP. Clinical pharmacokinetics of everolimus. Clin Paharmacokinet. 2004;43:83-95.
13. Okhawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
14. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
15. Lopez-Neblina F, Toledo-Pereyra LH, Mirmiran R, et al. Time dependence of Na-nitroprusside administration in the prevention of neutrophil infiltration in the rat ischemic kidney. Transplantation. 1996;61:179-183.
16. Sahna E, Parlakpinar H, Ozturk F, et al. The protective effects of physiological and pharmacological concentrations of melatonin on renal ischemia-reperfusion injury in rats. Urol Res. 2003;31:188-193.
17. Adkins JR, Silendirresena MR, Wang Z, et al. Rapamycin inhibits release of tumor necrosis factor-a from human vascular smooth muscle cells. Am Surg. 2004;70:384-387.
18. Donahoo KK, Shames BD, Harken AH, et al. The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol. 1999;162:196-203.
19. Meldrum KK, Meldrum DR, Hile KL. p38MAPK mediates renal tubular cell TNF-a production and TNF-a dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol. 2001;281:563-570.
20. Donnahoo KK, Meldrum DR, Shenkar R, et al. Early renal ischemia, with or without reperfusion, activates NFkB and increases TNF-a bioactivity in the kidney. J Urol. 2000;163:1328-1332.
21. Donnahoo KK, Meng X, Ao L, et al. Differential cellular immunolocalization of renal tumor necrosis factor-a production during ischemia versus endotxaemia. Immunology. 2001;102:53-58.
22. Patel NSA, Chatterjee PK, Di Paola R. Endogenous interleukin- 6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exper Ther. 2005;312:1170-1178.
23. Yokota N, O'Donnell M, Daniels F. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol. 2003;23:13-17.
24. Baud L, Ardaillou R. Involvement of reactive oxygen species in kidney damage. Br Med Bull. 1993;49:621-629.
25. Greene EL, Paller MS. Oxygen free radicals in acute renal failure. Miner Electrolyte Metab. 1991;17:124-132.
26. Dobashi K, Ghosh B, Orak JK, et al. Kidney ischemiareperfusion: Modulation of antioxidant defenses. Mol Cell Biochem. 2000;205:1-11.
27. Ysebaert DK, De Greef KE, Vercauteren SR. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant. 2000;15:1562-1574.
28. Daniel C, Renders L, Amann K, et al. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat. Am J Transplant. 2005;5:2849-2861.
29. Goncalves GM, Cenedeze MA, Feitoza CQ.The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury. Kidney Int. 2006;70:1742-1749.
30. Lieberthal W, Fuhro R, Andry CC. Rapamycin impairs recovery from acute renal failure: Role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol. 2001;281:693-706.